Vials And Ampoules Market Growth & Trends:
The global vials and ampoules market size is estimated to reach USD 15.45 billion by 2030, expanding at a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is predominantly driven by the rapid growth in the pharmaceutical industry mainly in emerging markets such as India and China. In addition, the COVID-19 pandemic has created a huge demand for vials and ampoules globally. The production of the COVID-19-vaccine at a large scale in various nations across the globe has significantly impacted the market scenario.
Companies such as Pfizer, Serum Institute of India, among other several biotechnology and pharmaceutical manufacturing companies are consistently doing R&D and developing vaccines with greater efficiency against coronavirus. The government of various nations has aimed to vaccinate the majority of their country's population by the end of 2021. Thus, vials and ampoules manufacturers are ramping up their production capacity multi-folds. India is among the top worst hit nations in the world. Moreover, the government of India is aiming to vaccinate the majority of the 137 crores Indian population by the end of 2021. This, further accelerate the demand for vials in India.
Various vials and ampoule manufacturing companies such as Schott Kaisha and Gerresheimer India are scaling up their capacity in India. For instance, Gerresheimer India is planning to increase its capacity by 30.0%. Companies are developing hybrid plastic and glass vials and ampoules with increased durability and low cost. Such innovations by the market players are expected further increase their product demand in the global market.
Vials And Ampoules Market Report Highlights:
- The glass segment dominated the global vials and ampoules industry and accounted for the largest revenue share of 76.4% in 2024. Glass is the most extensively used packaging material in the pharmaceutical industry owing to its properties such as non-reactive, non-corrosive, reusable, and recyclable properties
- The plastic segment is expected to grow at a CAGR of 8.6% over the forecast period. Plastic vials are cost-effective, durable, and lightweight. Moreover, plastic gives design flexibility. Such factors are increasing the demand for plastic material in the manufacturing of vials and ampoules
- India is the second-largest market for ampoules and vials in terms of value in Asia Pacific. This is due to the huge production of generic medicines in India. India is the largest supplier of generic pharmaceutical products in the world. Moreover, the recent outbreak has increased the demand for vials and ampoules in India
- Pharmaceutical companies such as Serum Institute of India and Bharat Biotech have developed the COVID-19 vaccines i.e., Covishield and Covaxin. The production of these vaccines is on large scale, which further requires a huge number of vials. Thus, India is one of the major markets for vials and ampoules in recent times
- Among the product segment, the ampoules segment accounted for a majority of the revenue share in 2020. Ampoules are low-cost compared to vials. In the pharmaceutical industries and hospitals, doctors normally give 1ml to 3ml of vaccines to a patient which mainly comes in the ampoules format
- In September 2024, Gerresheimer, SCHOTT Pharma, and Stevanato Group have formed a strategic partnerhsip to support the implementation of ready-to-use (RTU) cartridges and vials in the pharmaceutical industry. This alliance is called "Alliance for RTU", aims to share expertise on sterile primary packaging of high-quality, specifically focusing on RTU configurations over traditional bulk packaging. By adopting RTU setups, pharmaceutical companies can reduce operational risks and improve efficiency. The alliance seeks to create an open platform to educate manufacturers on the benefits of RTU processes, helping them evaluate investments for transformation to effective filling systems, ensuring safer medication delivery in vials and ampoules.